Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.

Tacke RS, Lee HC, Goh C, Courtney J, Polyak SJ, Rosen HR, Hahn YS.

Hepatology. 2012 Feb;55(2):343-53. doi: 10.1002/hep.24700.

2.

Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.

Liu CY, Wang YM, Wang CL, Feng PH, Ko HW, Liu YH, Wu YC, Chu Y, Chung FT, Kuo CH, Lee KY, Lin SM, Lin HC, Wang CH, Yu CT, Kuo HP.

J Cancer Res Clin Oncol. 2010 Jan;136(1):35-45. doi: 10.1007/s00432-009-0634-0.

PMID:
19572148
3.
4.

Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.

Goh CC, Roggerson KM, Lee HC, Golden-Mason L, Rosen HR, Hahn YS.

J Immunol. 2016 Mar 1;196(5):2283-92. doi: 10.4049/jimmunol.1501881. Epub 2016 Jan 29.

5.

Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.

Ren JP, Zhao J, Dai J, Griffin JW, Wang L, Wu XY, Morrison ZD, Li GY, El Gazzar M, Ning SB, Moorman JP, Yao ZQ.

Immunology. 2016 Aug;148(4):377-86. doi: 10.1111/imm.12616. Epub 2016 Jun 22.

6.

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.

Lechner MG, Liebertz DJ, Epstein AL.

J Immunol. 2010 Aug 15;185(4):2273-84. doi: 10.4049/jimmunol.1000901. Epub 2010 Jul 19. Erratum in: J Immunol. 2010 Nov 1;185(9):5668.

7.

IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.

Salem ML, Zidan AA, Attia M, El-Naggar RE, Nassef M, Abou El-Azm AR, El-Bate H, Yussif M, Galal S, Abo Senna M, El Demellawy M.

Immunopharmacol Immunotoxicol. 2017 Aug;39(4):188-198. doi: 10.1080/08923973.2017.1320670. Epub 2017 May 4.

PMID:
28472907
8.

HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.

Garg A, Spector SA.

J Infect Dis. 2014 Feb 1;209(3):441-51. doi: 10.1093/infdis/jit469. Epub 2013 Sep 1.

9.

Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.

Zhai N, Li H, Song H, Yang Y, Cui A, Li T, Niu J, Crispe IN, Su L, Tu Z.

PLoS One. 2017 Jan 23;12(1):e0170516. doi: 10.1371/journal.pone.0170516. eCollection 2017.

10.

Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling.

Pang X, Song H, Zhang Q, Tu Z, Niu J.

Clin Immunol. 2016 Mar;164:57-64. doi: 10.1016/j.clim.2016.01.014. Epub 2016 Jan 25.

PMID:
26821305
11.

Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling.

Wang M, Ping Y, Li Z, Li J, Zhang Z, Yue D, Chen X, Wang L, Huang L, Huang J, Yang L, Zhao X, Yang S, Li H, Shi J, Li J, Zhang Y.

J Viral Hepat. 2018 Oct 19. doi: 10.1111/jvh.13024. [Epub ahead of print]

PMID:
30339295
12.

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

Raychaudhuri B, Rayman P, Ireland J, Ko J, Rini B, Borden EC, Garcia J, Vogelbaum MA, Finke J.

Neuro Oncol. 2011 Jun;13(6):591-9. doi: 10.1093/neuonc/nor042.

13.

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.

Görgün GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, Raje N, Munshi NC, Richardson PG, Anderson KC.

Blood. 2013 Apr 11;121(15):2975-87. doi: 10.1182/blood-2012-08-448548. Epub 2013 Jan 15.

14.

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells.

Obermajer N, Muthuswamy R, Lesnock J, Edwards RP, Kalinski P.

Blood. 2011 Nov 17;118(20):5498-505. doi: 10.1182/blood-2011-07-365825. Epub 2011 Oct 4.

15.

Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.

Cai W, Qin A, Guo P, Yan D, Hu F, Yang Q, Xu M, Fu Y, Zhou J, Tang X.

J Clin Immunol. 2013 May;33(4):798-808. doi: 10.1007/s10875-012-9861-2. Epub 2013 Jan 26.

PMID:
23354838
16.

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.

Yu J, Du W, Yan F, Wang Y, Li H, Cao S, Yu W, Shen C, Liu J, Ren X.

J Immunol. 2013 Apr 1;190(7):3783-97. doi: 10.4049/jimmunol.1201449. Epub 2013 Feb 25.

17.

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, Whiteside TL.

J Immunol Methods. 2012 Jul 31;381(1-2):14-22. doi: 10.1016/j.jim.2012.04.004. Epub 2012 Apr 13.

18.

Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study.

Chen H, Qin S, Lei A, Li X, Gao Q, Dong J, Xiao Q, Zhou J.

Int Immunopharmacol. 2017 Jun;47:150-158. doi: 10.1016/j.intimp.2017.03.026. Epub 2017 Apr 11.

PMID:
28407569
19.

A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.

Vetsika EK, Koinis F, Gioulbasani M, Aggouraki D, Koutoulaki A, Skalidaki E, Mavroudis D, Georgoulias V, Kotsakis A.

J Immunol Res. 2014;2014:659294. doi: 10.1155/2014/659294. Epub 2014 Nov 11.

20.

T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.

Yao ZQ, King E, Prayther D, Yin D, Moorman J.

Viral Immunol. 2007 Summer;20(2):276-87.

PMID:
17603844

Supplemental Content

Support Center